EcoDrugPlus

Carbonic Anhydrase 2

Ensembl ID : ENSSTOG00000013370
Gene Symbol: CA2
3 Cross references
282 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSSTOG00000016161
Gene Symbol: CA3
3 Cross references
307 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSSTOG00000010432
Gene Symbol: CA4
3 Cross references
267 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSSTOG00000029850
Gene Symbol: CA5A
3 Cross references
167 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSSTOG00000008481
Gene Symbol: CA5B
3 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSSTOG00000012023
Gene Symbol: CA6
4 Cross references
218 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSSTOG00000021436
Gene Symbol: CA7
4 Cross references
220 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSSTOG00000005040
Gene Symbol: CA9
3 Cross references
280 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSSTOG00000005334
Gene Symbol: CSNK1E
3 Cross references
268 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSSTOG00000008643
Gene Symbol: CSNK2A1
3 Cross references
209 Possible Orthologues:

Caspase 8

Ensembl ID : ENSSTOG00000011342
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase-1-Like

Ensembl ID : ENSSTOG00000007964
Gene Symbol: LOC101954543
3 Cross references
450 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).